Production & Manufacturing

GlaxoSmithKline has teamed up with Xiamen Innovax Biotech to evaluate a vaccine against the novel coronavirus behind the COVID-19 pandemic. The agreement gives Innovax access to a GSK adjuvant to enhance the immune response triggered by its recombinant protein-based...

Gilead Sciences has been ramping up production of its experimental remdesivir treatment that is being tested to combat the novel coronavirus. The drug maker now has 1.5 million individual dosages that could be used for more than 140,000 patients and...

Sense has announced an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic. Sense is partnering closely with Phillips-Medisize, a Molex company and leading global medical device innovator,...

Univercells has launched a contract development and manufacturing organization (CDMO), Exothera, to support cell and gene therapy developers with process development and production of viral vectors. The company has been created to help alleviate the two most critical challenges...

Spray drying specialist and capsule filling service provider Micro-Sphere is investing 3.5 million CHF (€3.2 million) into expanding its GMP manufacturing capabilities and processes. Micro-Sphere will add an additional spray drying line to its facility in Switzerland in response to...

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, is investing $1.5m into a phased expansion of its US facility in North Carolina. The investment follows the acquisition of the former US CiVentiChem site earlier this year. Over the...

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that its Covance Drug Development business celebrated the opening of its new R&D Center in Shanghai, China, which is now its largest facility...